NCT04659785 2020-12-09A Study of Fluzoparib Combined With Apatinib as Second-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer（FA-ES-SCLC）Tianjin Medical University Second HospitalPhase 1/2 Unknown53 enrolled